Ticker
$RCKT
1 catalyst touching RCKT in the last 60 days, newest first, each with the price move that followed.
- 75
RCKT secures $150M term loan facility from Hercules Capital
Rocket Pharmaceuticals entered a loan and security agreement with Hercules Capital on September 30, 2026, providing up to $150 million in senior secured term loans across five tranches, with $35 million funded immediately. This is material financing that extends RCKT's cash runway and provides access to capital tied to clinical milestones (Tranche 2 Milestone) and FDA approval of RP-A501 for Danon Disease (Approval Milestone), de-risking near-term operations and enabling continued development of its pipeline.
RCKT ▲SEC 8-K · 6 Oct 2026, 21:15 UTC
Information only. AURA does not give buy or sell recommendations.